Naxifylline

DB06471ExperimentalSmall molecule

Investigated for use/treatment in congestive heart failure.

Mechanism: Pharmacologically active on Adenosine receptor A1
Curator reviewed
Primary indication: Investigated for use/treatment in congestive heart failure.Curator reviewed
Formula / weight: C₁₉H₂₅N₃O₃ · 343.427 g/mol (avg)
Code names: BG9719 · CVT-124

Resolves to

Compound

Structure

InChIKeyNJYNSYQBNSDGIQ-RDDCQWBRSA-NSMILES[H][C@]12O[C@@]1([H])[C@@]1([H])C[C@]2([H])C[C@@H]1C1=NC2=C(N1)N(CCC)C(=O)C(CCC)C2=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Naxifylline, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.